Product information
From Health Canada
Current status:
Cancelled Post Market
Current status date:
2002-06-10
Original market date: See footnote 1
1994-12-31
Product name:
WYDASE INJECTION LIQ 150 UNITS/ML
DIN:
02041278 Electronic product monograph is not available
Company:
WYETH-AYERST CANADA INC.
1025 Marcel Laurin Blvd.
St. Laurent
Quebec
Canada
H4R 1J6
Class:
Human
Dosage form(s):
Liquid
Route(s) of administration:
Block/Infiltration , Subcutaneous
Number of active ingredient(s):
1
Schedule(s):
Schedule D
American Hospital Formulary Service (AHFS): See footnote 3
44:00.00
Anatomical Therapeutic Chemical (ATC): See footnote 4
B06AA03 HYALURONIDASE
Active ingredient group (AIG) number:See footnote5
0107586001
Active ingredient(s) | Strength |
---|---|
HYALURONIDASE | 150 UNIT / ML |